Latest News

What is a relevant change in ADAS-cog?

 

A 3-point change in the Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-cog) score appears to be the minimal clinically relevant change for patients with mild Alzheimer’s disease (Schrag et al. J Neurol Neurosurg Psychiatry 2012;83:171-173).

Read More

TOPICS:

Oral anti-alpha4-integrin in development

 

Firategrast, an oral formulation of a natalizumab-like small molecule, produces a significant reduction in MRI lesions, according to the results of a phase II study (Miller et al. Lancet Neurol 2012; epublished January 5, 2012).

Read More

TOPICS:

Nicotine produces benefits in MCI

 

Administration of transdermal nicotine improves cognitive performance in patients with mild cognitive impairment (MCI), according to the results of a pilot study (Newhouse et al. Neurology 2012;78:91-101).

Read More

TOPICS: